U.S. Steel 1Q Revenue Drops on Lower Prices, Weaker Shipments
By Ben Glickman
U.S. Steel posted lower revenue in the first quarter after drops in prices for some of the company's segments weighed on results.
The Pittsburgh-based company reported a profit of $171 million, or 68 cents a share, in the quarter ended March 31, compared with a profit of $199 million, or 78 cents a share, a year earlier.
Stripping out certain one-time items, U.S. Steel had an adjusted profit of 82 cents a share.
Revenue fell to $4.16 billion from $4.47 billion a year ago.
Prices in U.S. Steel's flat-rolled and mini mill segments rose, while average realized prices in European operations and in tubular fell compared to a year ago. Total steel shipments declined.
Chief Executive David Burritt said the company benefited from a diverse order book and efficiently run operations. He noted results were dented by an unfavorable inventory impact in North American flat-rolled.
U.S. Steel said it was working toward closing the merger with Nippon Steel, and still expects the merger to close in the second half of 2024.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
May 02, 2024 17:14 ET (21:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software